Credit: NPG

Reporting in Immunity, Bluestone and colleagues show that a subset of fully committed forkhead box P3 (FOXP3)+ regulatory T (TReg) cells can become unstable in response to antigen activation during an inflammatory autoimmune response and participate in disease pathogenesis.

The concept of TReg cell instability is not new — previous studies have shown that TReg cells can lose FOXP3 expression (turning into 'exFOXP3' cells) and become pathogenic. However, it has been argued that exFOXP3 cells derive from an early, 'aborted' TReg cell differentiation pathway rather than from fully differentiated, thymus-derived TReg cells, which have been suggested to be stable. Determining the source of exFOXP3 cells has important clinical implications, as TReg cell-based therapies are currently in clinical trials and TReg cell instability could lead to unwarranted effects in patients.

In this study, the authors used C57BL/6 dual-reporter mice that allow for the identification of FOXP3+ TReg cells and exFOXP3 cells in the same animal. Experimental autoimmune encephalomyelitis (EAE; a mouse model of multiple sclerosis) was then induced in these mice using a myelin oligodendrocyte glycoprotein (MOG) antigen. Analysis of these mice showed that a subset of MOG-specific CD4+ TReg cells preferentially downregulated FOXP3 expression compared with polyclonal TReg cells during the induction and peak phases of the disease. However, FOXP3 expression was restored at a population level during the resolution of the inflammatory response, either because of reversion of the exFOXP3 cells or replacement by a more stable FOXP3+ TReg cell population.

bona fide TReg cells can lose FOXP3 expression and become exFOXP3 cells in inflammatory settings

To determine whether these exFOXP3 cells derive from bona fide TReg cells, the authors transferred purified TReg cells to mice during the onset of EAE. Most of the transferred polyclonal TReg cells maintained stable FOXP3 expression, whereas FOXP3 expression was significantly lower in transferred MOG-specific TReg cells, with FOXP3 being low or undetectable in 39% of these cells. Next, the authors examined the methylation status of CpG motifs in the TReg cell-specific demethylated region (TSDR) of the Foxp3 locus. Previous studies have shown that these motifs are fully methylated in unstable TReg cells and conventional T cells but are demethylated in TReg cells. Interestingly, the CpG motifs in the TSDR of MOG-specific exFOXP3 cells isolated from the central nervous system (CNS) during the peak of EAE were predominantly demethylated, which supports the hypothesis that bona fide TReg cells can lose FOXP3 expression and become exFOXP3 cells in inflammatory settings.

But do these cells contribute to disease pathogenesis? CNS-derived exFOXP3 cells that were stimulated in vitro produced interferon-γ at levels comparable with those produced by pathogenic effector T cells. Furthermore, transferred MOG-specific exFOXP3 cells induced EAE in T cell-deficient mice with similar incidence and severity to that induced by pathogenic effector T cells.

Interleukin-2 (IL-2) is crucial for the expression of FOXP3 in TReg cells, and the authors showed that treatment of mice with complexes of IL-2 and non-neutralizing IL-2-specific antibodies at the initiation of EAE reduced the proportion and number of MOG-specific exFOXP3 cells. The treated mice were shown to be protected from disease.

These data show that bona fide self-antigen-specific TReg cells can become unstable and contribute to a pathogenic immune response in a mouse model of autoimmunity, but this instability can be rescued by treatment with IL-2–IL-2-specific antibody complexes.